Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 4, 2020

View Archived Issues

Telix cleared to begin first-in-human study of TLX-592 for prostate cancer

Deglycosylated receptor-binding domain recombinant proteins as scalable SARS-CoV candidates

Novel Nav1.7 channel inhibitor with potent analgesic activity in a mouse model of neuropathic pain

First patient dosed in phase I study of FS-120

Positive interim data from phase II study of Allocetra in severe and critical COVID-19

Updated data presented from ongoing DeCidE1 study of DPX-Survivac

Chugai describes antigen-binding molecules targeting C1s

Initiation of phase I study of QPX-7728 for drug-resistant bacterial infections

Positive data from GLP toxicology study of EYP-1901

Sirnaomics to start phase I trial of STP-705 in liver cancer

Zhejiang Hisun Pharmaceutical, Shanghai Aryl Pharmtech describe AGTR2 antagonists

New EGFR inhibitors discovered at Zhejiang University

Henan Zhiwei Biomedicine, Henan Normal University present new BTK inhibitors

GEMoaB begins first-in-human study of UniCAR-T-PSMA

Yangtze River Pharmaceutical, Shanghai Haiyan Pharmaceutical Technology patent PD-1/PD-L1 inhibitors

FDA accepts IND application for MicroLine as treatment of presbyopia

Serotonin found to differentially promote patience

Small molecule TNF-alpha inhibitors from UCB Pharma display efficacy in arthritis models

Phase III study of masitinib in first-line pancreatic cancer with pain shows survival increase

Sotagliflozin data presented in patients with type 2 diabetes with cardiac or renal complications

FDA approves oral once-daily Orladeyo to prevent HAE attacks

CV outcomes from FIDELIO-DKD trial of finerenone in patients with CKD and T2D

New phase II trial investigates silmitasertib for moderate COVID-19

Ascletis advances envafolimab into phase IIb for chronic hepatitis B

Researchers develop a feline model of heart failure with preserved eject fraction

Clover reports phase I data on adjuvanted S-Trimer COVID-19 vaccine candidates

Tevard and Zogenix collaborate on novel tRNA-based gene therapies for genetic epilepsies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
EASL spotlight: TUNE-401 advances epigenetic silencing in HBV
BioWorld
Several presentations at EASL highlight a new generation of therapies coming into view, with the work from Tune Therapeutics Inc. standing out as one of the most...